Skip to content
Free 24/7 Consultation | "Call The Champs"
At NST Law, we are dedicated to helping injured individuals and their families get the justice and compensation they deserve.
Mr. Trotz has handled personal injury cases involving car accidents, trucking accidents, slip and fall, premises liability, and negligent security. Each and every day, Mr. Trotz represents those who have been injured through no fault of their own, and many of his clients have sustained traumatic, catastrophic and life-altering injuries.
Belviq (lorcaserin) is a diet medication manufactured by Eisai Inc. that was approved by the U.S. Food & Drug Administration (FDA) in 2012. Belviq was approved for weight management in adults considered obese and overweight. In 2016, Belviq XR (extended release) was approved by the FDA. The FDA, on February 13, 2020, issued a recall for Belviq and Belviq XR after clinical trials demonstrated a link between the drug and increased occurrence of cancer, including pancreatic, lung, and colorectal cancer. The prescription drug and medication lawyers of Nahon, Saharovich & Trotz are currently investigating cases involving Belviq and cancer.
Belviq is a popular weight-loss drug prescribed by doctors. It is sometimes prescribed to treat obesity related to diabetes, high cholesterol, or high blood pressure. When prescribed, doctors also instruct patients to monitor their diet and exercise. Belviq is designed to affect chemical signals in the patient’s brain which control their appetite. By altering the chemical signals and receptors, Belviq is intended to help patients feel “full” despite eating smaller meals and portion sizes.
When approving Belviq in 2012, the FDA asked the manufacturer to conduct a clinical trial to evaluate the risk of heart-related problems. The trial, conducted among 12,000 participants over 5 years, ended up revealing that more patients taking Belviq were diagnosed with cancer compared to participants taking a placebo. In January 2020, the FDA announced it was reviewing the clinical trial data and alerted the public of a possible risk of cancer. In turn, healthcare professionals were instructed to carefully consider the potential risks and side effects of Belviq when prescribing the medication.
In February 2020, the FDA formally requested that Eisai Inc., the manufacturer of Belviq and Belviq XR, voluntarily remove the weight-loss drug from the U.S. market based on the clinical trial results. Further, based on Belviq’s link to cancer as revealed by the clinic trials, healthcare professionals were warned to stop prescribing and dispensing Belviq and lorcaserin to patients altogether.
The FDA currently recommends that all patients stop taking Belviq immediately. Patients prescribed the drug should discuss alternative treatment, strategies, or medication for weight loss.
If you have been prescribed Belviq, you should consult with a doctor immediately. Patients who took Belviq and developed cancer may be eligible to file a Belviq lawsuit. If you developed pancreatic, lung, colorectal, or another form of cancer after taking Belviq, a lawyer can explain and protect your rights. You may also contact our law firm on behalf of a loved one.
In a pharmaceutical drug lawsuit, the injured patient (or their estate, if deceased) can recover compensation for past and future damages. A Belviq lawyer can help you and your loved ones recover compensation from the drug manufacturer, which may include:
You should consult with an attorney as soon as possible to discuss your rights and ensure they remain protected. Each state has a specific statute of limitation within which a lawsuit must be properly filed in court. Certain pharmaceutical drug and product liability cases can become class action lawsuits, and your lawyer can make sure everything is properly filed in the appropriate court and jurisdiction. Further, a lawyer experienced in pharmaceutical and prescription drug litigation will need to take steps to preserve evidence and help develop your case, including consulting with expert witnesses who are qualified to prove the link between Belviq and your cancer diagnosis.
The prescription drug and medical device lawyers of Nahon, Saharovich & Trotz are currently evaluating cases involving Belviq users who developed cancer, including colorectal cancer, pancreatic cancer, and lung cancer. If you were prescribed Belviq and later diagnosed with cancer, call NST Law at 800-529-4004 or complete our online form for a free, confidential, and no-obligation consultation with a lawyer today. Nahon, Saharovich & Trotz has offices throughout the Southeast including Tennessee, Mississippi, Arkansas, and Missouri. Let us show you why NST is the way to go.
Memphis Office
488 S. Mendenhall Road
Memphis, TN 38117
Phone: 901-582-6035
Fax: 901-462-3350
Knoxville Office
408 N. Cedar Bluff Road Suite 450
Knoxville, TN 37923
Phone: 865-390-7229
Fax: 865-934-4364
Jackson, TN Office
2709 N. Highland Avenue
Jackson, TN 38305
Phone: 731-257-2616
Fax: 731-951-0090
Tupelo Office
201 Magazine Street Suite 201
Tupelo, MS 38804
Phone: 662-840-9222
Fax: 662-840-7745
Jonesboro Office
317 Southwest Drive Suite B
Jonesboro, AR 72401
Phone: 870-372-6882
Fax: 870-972-8852
Little Rock Office
4 Shackleford Plaza Suite 211
Little Rock, AR 72211
Phone: 501-381-3391
Fax: 501-891-5036
St. Louis Office
701 Market St Suite 285
St. Louis, MO 63101
Phone: 314-476-0500
Fax: 314-476-0006
Cape Girardeau Office
1918 N. Kingshighway Suite 102
Cape Girardeau, MO 63701
Phone: 573-262-9311
Fax: 573-803-1389
Belleville Office
6400 W Main St. Suite 10
Belleville, IL 62223
Phone: 618-746-2828
Fax: 618-746-2899
“CALL THE CHAMPS!” | AVAILABLE 24/7
"*" indicates required fields
